ANRO (Alto Neuroscience) Short Ratio


ANRO Alto Neuroscience Inc ANRO
12 GF Score
Price $26.22
! 1 Warning Sign
View Full Analysis

What is Alto Neuroscience Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ANRO
12GF Score
Alto Neuroscience Inc ANRO
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alto Neuroscience Business Description

Address 650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
12GF Score

Get the complete analysis for ANRO

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.22
Price